WindMIL Therapeutics
WindMIL Therapeutics is evolving. An exciting future lies ahead...
Founded 2015
Baltimore, United States
11 employees
Series B
Total: $42.50M
Biotechnology, Health and Wellness +1
Baltimore, United States
11 employees
Series B
Total: $42.50M
Biotechnology, Health and Wellness +1
General Information
Company Name
WindMIL Therapeutics
Founded Year
2015
Location
Baltimore, United States
Baltimore, United States
Employees
11
Industries
Biotechnology, Health and Wellness, Medical Devices
Funding Stage
Series B
Social
BounceWatch is an independent company data service, not affiliated with WindMIL Therapeutics. To contact WindMIL Therapeutics, visit windmiltx.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does WindMIL Therapeutics compare?
A PDF of WindMIL Therapeutics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting WindMIL Therapeutics soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
From the desk
Is WindMIL Therapeutics on your competitive set?
Our desk can watch it and brief you on every move: hiring, funding, leadership, product and pricing.
Book a 7-day ReadoutDiscover More
United States Market
Biotechnology
About WindMIL Therapeutics
Business keywords: Cell therapy, Cancer treatment, Marrow Infiltrating Lymphocytes, Immunology, Memory T cells, Bone marrow, Cancer research, Life-saving therapies, Healthcare innovation
Funding Rounds & Investors (2)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Series B | $32.50M | 5 |
|
18 Jun 2018 |
| Series A | $10.00M | 1 |
Scott H. Cohen
|
07 Apr 2016 |
WindMIL Therapeutics Alternatives & Competitors
View All Alternatives
WindMIL Therapeutics vs
Neogene Therapeutics
The Netherlands
Pushing the frontier by pioneering next-generation engineered T cell receptor therapies for solid ca...
Acquired
45 employees
Biotechnology, Health Care
WindMIL Therapeutics vs
CREATE Medicines
United States
CREATE Medicines is a clinical-stage biotech pioneering in vivo multi-immune programming. Its propri...
Series A
43 employees
Biotechnology, Health and Wellness
WindMIL Therapeutics vs
Grit Biotechnology
China
Developing novel cell therapies to transform the lives of people with cancer.
Series B
10 employees
Biotechnology, Health Care
FAQ About WindMIL Therapeutics
WindMIL Therapeutics is evolving. An exciting future lies ahead...
WindMIL Therapeutics was founded in 2015.
WindMIL Therapeutics is headquartered in Baltimore, United States.
WindMIL Therapeutics operates in Biotechnology, Health and Wellness and Medical Devices. Its work centres on Cell therapy, Cancer treatment, Marrow Infiltrating Lymphocytes and Immunology.
WindMIL Therapeutics has approximately 11 employees.
WindMIL Therapeutics has completed 2 funding rounds, raising a total of $42.50M. The latest funding stage is Series B.
Top alternatives and competitors to WindMIL Therapeutics include Neogene Therapeutics, CREATE Medicines, Grit Biotechnology, Garuda Therapeutics, GammaDelta Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
WindMIL Therapeutics and Neogene Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.
Source: BounceWatch company record for WindMIL Therapeutics, https://bouncewatch.com/company/windmil-therapeutics, updated 9 June 2026. When citing, please name BounceWatch and link this page.
